Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry K Keefer

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry|October 22, 2008
Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugsHarinath Chakrapani, Ravi C Kalathur, Anna E Maciag, et al.
Bioorganic & Medicinal Chemistry|June 6, 2015
PABA/NO lead optimization: Improved targeting of cytotoxicity to glutathione S-transferase P1-overexpressing cancer cellsYouseung Kim, Anna E Maciag, Zhao Cao, et al.
Nitric Oxide : Biology and Chemistry|March 21, 2006
Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450Keiko Inami, Raymond W Nims, Aloka Srinivasan, et al.
Chemical Research in Toxicology|May 29, 2012
Richard Loeppky (1937-2012)Gerhard Eisenbrand, Kent S Gates, Stephen S Hecht, et al.
Nitric Oxide : Biology and Chemistry|March 3, 2005
The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular levelWei Qu, Jie Liu, Richard Fuquay, et al.
Organic Letters|December 4, 2009
Glycosylated PROLI/NO derivatives as nitric oxide prodrugsRahul S Nandurdikar, Anna E Maciag, Sam Y Hong, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compoundRahul S Nandurdikar, Anna E Maciag, Michael L Citro, et al.
The International Journal of Biological Markers|December 17, 2010
Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studiesBarbara J Fuhrman, Xia Xu, Roni T Falk, et al.
Leukemia Research|February 6, 2009
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)Paul J Shami, Anna E Maciag, Jordan K Eddington, et al.
International Journal of Cancer|April 2, 2011
Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomasEvangelos Kogias, Nadja Osterberg, Brunhilde Baumer, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry|October 22, 2008
Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugsHarinath Chakrapani, Ravi C Kalathur, Anna E Maciag, et al.
Bioorganic & Medicinal Chemistry|June 6, 2015
PABA/NO lead optimization: Improved targeting of cytotoxicity to glutathione S-transferase P1-overexpressing cancer cellsYouseung Kim, Anna E Maciag, Zhao Cao, et al.
Nitric Oxide : Biology and Chemistry|March 21, 2006
Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450Keiko Inami, Raymond W Nims, Aloka Srinivasan, et al.
Chemical Research in Toxicology|May 29, 2012
Richard Loeppky (1937-2012)Gerhard Eisenbrand, Kent S Gates, Stephen S Hecht, et al.
Nitric Oxide : Biology and Chemistry|March 3, 2005
The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular levelWei Qu, Jie Liu, Richard Fuquay, et al.
Organic Letters|December 4, 2009
Glycosylated PROLI/NO derivatives as nitric oxide prodrugsRahul S Nandurdikar, Anna E Maciag, Sam Y Hong, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compoundRahul S Nandurdikar, Anna E Maciag, Michael L Citro, et al.
The International Journal of Biological Markers|December 17, 2010
Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studiesBarbara J Fuhrman, Xia Xu, Roni T Falk, et al.
Leukemia Research|February 6, 2009
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)Paul J Shami, Anna E Maciag, Jordan K Eddington, et al.
International Journal of Cancer|April 2, 2011
Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomasEvangelos Kogias, Nadja Osterberg, Brunhilde Baumer, et al.
Pageof 12